California sues DuPont over alleged effort to avoid ‘forever chemicals’ liabilities - FT中文网
登录×
电子邮件/用户名
密码
记住我
请输入邮箱和密码进行绑定操作:
请输入手机号码,通过短信验证(目前仅支持中国大陆地区的手机号)。如果该手机号尚未注册,将自动创建 FT中文网账号。短信可能需要几分钟送达,验证码15分钟内有效,请耐心等待:
请您阅读我们的用户注册协议和隐私权保护政策,点击下方按钮即视为您接受。
商业快报

California sues DuPont over alleged effort to avoid ‘forever chemicals’ liabilities

State’s attorney-general says lawsuit involves ‘first-of-its-kind’ litigation
00:00

{"text":[[{"start":9.02,"text":"California is suing DuPont de Nemours, alleging the company fraudulently transferred assets to shelter them from creditors seeking compensation for harm caused by its products over several decades."}],[{"start":21.34,"text":"The new suit is part of litigation against some of America’s largest chemical companies over “forever chemicals”, which include substances used in products such as non-stick frying pans, cleaning sprays and firefighting foam."}],[{"start":34.84,"text":"The chemicals — PFAS, or per- and polyfluoroalkyl substances — have been linked to health issues including reduced kidney and liver function and infertility. They are the subject of multibillion-dollar compensation claims against US and other manufacturers."}],[{"start":50.32,"text":"In a filing to a federal court in South Carolina on Thursday, Rob Bonta, California’s attorney-general, asked the court to prevent DuPont and its recently spun-off electronics business Qnity from transferring any proceeds from asset sales that were part of DuPont before it merged with The Dow Chemical Company in 2017."}],[{"start":68.88,"text":"The lawsuit, which Bonta described as “first-of-its-kind litigation”, alleges “wrongful conduct” as part of a continuing fraudulent transaction scheme that is illegal and designed to evade accountability over PFAS claims and liabilities."}],[{"start":82.96,"text":"The litigation follows separate court battles over companies’ use of controversial restructuring schemes involving bankruptcy law to shield assets from claims in mass tort cases. 3M, another manufacturer of PFAS, dropped its attempted use of a bankruptcy scheme following a court defeat in 2023."}],[{"start":100.72,"text":"DuPont declined to comment."}],[{"start":102.64,"text":"The latest claims by Bonta follow his filing of a PFAS lawsuit in 2022 against DuPont, 3M and more than a dozen other chemical manufacturers, alleging they had endangered public health, caused irreparable harm to the state’s natural resources, and deceived the public."}],[{"start":119.08,"text":"In the amended complaint filed on Thursday, Bonta alleges DuPont engaged in a series of fraudulent transfers designed to evade creditors such as California by covering up the transfer of assets between spin-off companies."}],[{"start":132,"text":"“These transactions were performed with the real intent to hinder, delay and defraud creditors or future creditors,” according to Bonta."}],[{"start":138.24,"text":"He alleges the transfer of rights to receive insurance proceeds from PFAS-related liabilities from Chemours, a DuPont spin-off created in 2015, to DuPont and Corteva, a 2019 spin-off, was a fraudulent transfer."}],[{"start":152,"text":"These rights were transferred for a sum that amounted to less than half the estimated insurance proceeds, the filing alleges. Nonetheless, Chemours will be responsible for indemnifying Corteva, DuPont and the previous DuPont company that existed before its merger with Dow."}],[{"start":172.16,"text":""}]],"url":"https://audio.ftcn.net.cn/album/a_1786077255_7774.mp3"}

版权声明:本文版权归FT中文网所有,未经允许任何单位或个人不得转载,复制或以任何其他方式使用本文全部或部分,侵权必究。

英伟达董事会的虚假独立性

治理话题令人犯困。

中国科技股大幅回落,投资AI或许少些波折

中国的机遇同样蕴藏在AI供应链的“卖铲人”环节。

英伟达的个人崇拜注定不会善终

值得留意企业傲慢自大的警讯——这往往意味着坏事即将发生。

无根之人最终赢了

人们或许不会投票支持自由个人主义,但他们践行着它。

耗资5亿美元的罗摩衍那押注全球成功

宝莱坞史上成本最高的电影更看重CGI视觉奇观,而非精神震撼——但要收回成本,或许还得靠奇迹。

我们很快就能治愈癌症吗?

近期,药物预防和治疗领域的革命性进展让科学家距离战胜这些最令人恐惧的疾病仅一步之遥,但棘手的挑战依然存在。
设置字号×
最小
较小
默认
较大
最大
分享×